INIGIMA Cloud Diagnosis Early cancer detection focuses on recognising symptomatic changes
Cancer affects everyone – young and old, rich and poor, men, women, and children – and places a significant financial and emotional strain on patients, families, and society. Cancer is one of the world's major causes of death.
Many of these deaths, however, can be averted. Healthy lifestyle changes like quitting smoking and public health initiatives like immunisation against cancer-causing illnesses can prevent 30-50 percent of cancers. Others, on the other hand, can be recognised early, treated, and cured. Even in advanced stages of cancer, proper palliative care can help patients feel better.
Early cancer detection focuses on recognising symptomatic individuals as soon as feasible so that they can receive the best therapy available.
When cancer therapy is delayed or unavailable, there is a reduced likelihood of survival, more treatment complications, and higher treatment expenses.
Early detection improves cancer outcomes by allowing patients to receive treatment at the earliest feasible stage, and is thus an important public health approach in all settings.
Screening differs from early diagnosis in that it is a preventative measure. It is described as the presumptive detection of undiagnosed disease in an asymptomatic, apparently healthy population using tests, examinations, or other methods that may be applied quickly and easily to the target group. From inviting the target population to providing appropriate treatment for those found with disease, a screening programme must encompass all of the fundamental components of the screening process.
How does INIGIMA help to identify the early stage and progression of the disease?
The problem is no one can go to a Doctor or Diagnosis lab for a check-up yet it's important. But before any critical complication, it undergoes physiological changes that are key to identifying the progression of the disease.